Trials / Unknown
UnknownNCT01458158
Matrix Metalloproteinases in Atherosclerosis of Chronic Kidney Disease
The Role of Matrix Metalloproteinases -2 and -9 in Atherosclerosis of Patients With Chronic Kidney Disease
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- Aristotle University Of Thessaloniki · Academic / Other
- Sex
- All
- Age
- 50 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine whether matrix metalloproteinases are associated with atherosclerosis in the different stages of chronic kidney disease.
Detailed description
The purpose of this study is to determine the correlation of matrix metalloproteinases and atherosclerosis of chronic kidney disease. Patients with diabetes mellitus type 2,as a non-inflammatory leading cause of end stage renal failure and patients with chronic glomerulonephritis and similar course of proteinuria,as an inflammatory leading cause of end stage renal failure are enrolled.
Conditions
Timeline
- Start date
- 2011-10-01
- Primary completion
- 2016-05-01
- Completion
- 2016-05-01
- First posted
- 2011-10-24
- Last updated
- 2015-02-23
Locations
1 site across 1 country: Greece
Source: ClinicalTrials.gov record NCT01458158. Inclusion in this directory is not an endorsement.